Intravitreal injection device, system and method

• US 7,678,078 B1
• Filed: 10/21/2008
• Issued: 03/16/2010
• Est. Priority Date: 10/21/2008
• Status: Active Grant

• Current Assignee: KMG Pharma, LLC
• Original Assignee: KMG Pharma, LLC
• Inventors: Cormier, Michel Jean Noel, Peyman, Gholam A., Hosseini, Kamran
• Primary Examiner(s): Sirmons; Kevin C
• Assistant Examiner(s): Moulton; Elizabeth R
• Application Number:
  US12/288,510
• Time in Patent Office: 511 Days
• Field of Search: 604/521, 604/68, 604/116, 604/117
• US Class Current: 604/117
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts
• CPC Class Codes: A61M 2005/2407 from the rear
• CPC Class Codes: A61M 2005/2488 via rotation, e.g. threads or bayonet
• CPC Class Codes: A61M 2005/31516 reducing dead-space in the syringe barrel after delivery
• CPC Class Codes: A61M 5/24 Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic ampoules or carpules A61J1/06
• CPC Class Codes: A61M 5/46 having means for controlling depth of insertion

Abstract

An intravitreal injection device for administering a pharmacological agent formulation to an intravitreal compartment of an eye, comprising (i) a nozzle member having an internal formulation chamber that is adapted to receive and contain the pharmacological agent formulation therein, (ii) a microneedle having a first end that is in communication with the nozzle member and a second ejection end, (iii) and piercing depth limiter means for limiting the penetration depth of the microneedle into the eye, the microneedle piercing depth limiter means including guide means for positioning the limiter means and guiding the microneedle.

Claims

1. An intravitreal injection system, comprising:

a transfer mechanism, said transfer mechanism including a nozzle member and an integral microneedle-guide platform assembly, said microneedle-guide platform assembly having an integral microneedle and an integral guide platform, said nozzle member having an internal formulation chamber that is adapted to receive and contain a pharmacological agent formulation therein, said microneedle having a first end that is in communication with said nozzle member and a second ejection end, said guide platform having an eye contact surface and a predetermined degree of flexibility, whereby said guide platform substantially conforms to the surface of the sclera of an eye and positions said microneedle-guide platform assembly proximate the pars plana area of said eye when in an engagement position thereon, said guide platform further having a lumen disposed centrally thereof that is adapted to receive and guide said microneedle therethrough and into an intravitreal compartment of an eye and suction means that provides an eye engagement force and seals said guide platform to said pars plana area of said eye when said guide platform is in said engagement position,

said microneedle-guide platform assembly including anchoring means for anchoring said microneedle in said intravitreal compartment of said eye and microneedle piercing depth means for controlling the penetration depth of said microneedle into said intravitreal compartment of said eye to a range of approximately 0.1-1.0 mm when in said engagement position; and

a jet injector having force generating means that is adapted to generate sufficient force to expel said pharmacological agent formulation from said nozzle member and through said microneedle with an injection pressure in the range of approximately 50-1000 psi.

2. The system of claim 1, wherein the volume of said pharmacological agent formulation is in the range of approximately 0.025-0.2 ml.

3. The system of claim 1, wherein said guide platform comprises an elastic, biocompatible polymeric material.

4. The system of claim 1, wherein said guide platform has a substantially circular shape.

5. The system of claim 1, wherein said guide platform has a substantially crescent shape, said crescent shaped guide platform having first and second ends, a convex edge, and a concave edge.

6. The system of claim 5, wherein said microneedle is positioned substantially orthogonal to a plane defined by said crescent shaped guide platform first and second ends.

7. The system of claim 5, wherein said ejection end of said microneedle is directed towards said crescent shaped guide platform convex edge at an angle <

30°

.

8. The system of claim 1, wherein said guide platform is substantially star shaped, said star shaped guide platform having a plurality of arms.

9. The system of claim 1, wherein said suction means comprises a plurality of suction cups disposed on said guide platform eye contact surface.

10. The system of claim 1, wherein said suction means comprises at least one suction ring disposed on said guide platform eye contact surface.

11. The system of claim 1, including a formulation cartridge that is adapted to contain said pharmacological agent formulation, said cartridge being adapted to be slideably received in said internal formulation chamber of said nozzle member.

12. An intravitreal injection device for administering a pharmacological agent formulation to an intravitreal compartment of an eye, comprising:

a nozzle member having an internal formulation chamber that is adapted to receive and contain the pharmacological agent formulation therein;

an integral microneedle-guide platform assembly, said microneedle-guide platform assembly having an integral microneedle and an integral guide platform, said microneedle having a first end that is in communication with said nozzle member and a second ejection end, said guide platform having a lumen disposed centrally thereof that is adapted to receive and guide said microneedle therethrough, said guide platform further having an eye contact surface and a predetermined degree of flexibility, whereby said guide platform substantially conforms to the surface of the scleral membrane of an eye and positions said microneedle and guide platform assembly proximate the pars plana area of said eye when in an engagement position thereon,

said integral microneedle-guide platform assembly including microneedle guide means for guiding said microneedle into said scleral membrane of said eye, anchoring means for anchoring said microneedle in said scleral membrane at said pars plana area of said eye, controllable microneedle piercing depth penetration means for limiting the penetration depth of said microneedle into said scleral membrane of said eye, and suction means disposed on said guide platform eye contact surface that provides an eye engagement force and seals said microneedle-guide platform assembly to said pars plana area of said eye when said microneedle-guide platform assembly is in an engagement position on said eye.

13. The device of claim 12, wherein said device is adapted to engage and cooperate with a jet injector, said jet injector having force generating means that is adapted to generate sufficient force to expel the pharmacological agent formulation from said nozzle member and through said microneedle.

14. The device of claim 12, wherein said guide platform comprises an elastic, biocompatible polymeric material.

15. The device of claim 12, wherein said guide platform has a substantially circular shape.

16. The device of claim 12, wherein said guide platform has a substantially crescent shape.

17. The device of claim 12, wherein said guide platform is substantially star shaped.

18. The device of claim 12, wherein said suction means comprises a plurality of suction cups.

19. The device of claim 12, wherein said suction means comprises at least one suction ring.

20. A method for administering a pharmacological agent formulation to an intravitreal compartment of an eye, comprising the steps of:

providing an intravitreal injection system having a transfer mechanism and a jet injector, said transfer mechanism including a nozzle member and an integral microneedle-guide platform assembly, said microneedle-guide platform assembly having an integral microneedle and an integral guide platform, said nozzle member containing the pharmacological agent formulation in an internal formulation chamber, said microneedle having a first end that is in communication with said nozzle member and a second ejection end, said guide platform having an eye contact surface and a predetermined degree of flexibility, whereby said guide platform substantially conforms to the surface of a sclera of the eye when in an engagement position thereon, said guide platform further including suction means that provides an engagement force when said guide platform is in said engagement position on the eye, said guide platform further having a substantially crescent shape that includes a concave edge and a centrally located lumen that is adapted to receive said microneedle and guide said microneedle into said eye when said guide platform is in said engagement position on said eye, said microneedle-guide platform assembly providing a predetermined microneedle penetration depth into said eye in the range of approximately 0.1-1.0 mm when in said engagement position, said jet injector having force generating means that is adapted to generate sufficient force to expel the pharmacological agent formulation from said nozzle member and through said microneedle;

coupling said intravitreal injection system to said jet injector, whereby an intravitreal injection assembly is formed;

positioning said intravitreal injection assembly on the pars plana area of the eye by mating said concave edge of said crescent shaped platform proximate the junction of the cornea and sclera of the eye; and

activating said injector, whereby the pharmacological agent formulation is expelled from said nozzle member, through said microneedle and into the intravitreal compartment of the eye.

21. The method of claim 20, wherein said intravitreal injection assembly is positioned on the pars plana area of the eye by mating said concave edge of said crescent shaped platform proximate the junction of the cornea and corneoscleral limbus of the eye.

22. The method of claim 20, wherein the volume of said pharmacological agent formulation is in the range of approximately 0.025-0.2 ml.

23. The method of claim 20, wherein said jet injector provides an injection pressure in the range of approximately 50-1000 psi.